KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Operating Margin: 2010-2025

Historic Operating Margin for Nektar Therapeutics (NKTR) over the last 16 years, with Sep 2025 value amounting to -268.63%.

  • Nektar Therapeutics' Operating Margin fell 12627.00% to -268.63% in Q3 2025 from the same period last year, while for Sep 2025 it was -156.69%, marking a year-over-year increase of 764.00%. This contributed to the annual value of -106.88% for FY2024, which is 18571.00% up from last year.
  • According to the latest figures from Q3 2025, Nektar Therapeutics' Operating Margin is -268.63%, which was up 17.14% from -324.21% recorded in Q2 2025.
  • Nektar Therapeutics' Operating Margin's 5-year high stood at 49.18% during Q4 2024, with a 5-year trough of -708.07% in Q2 2022.
  • Its 3-year average for Operating Margin is -244.02%, with a median of -211.90% in 2024.
  • Per our database at Business Quant, Nektar Therapeutics' Operating Margin plummeted by 31,906bps in 2022 and then spiked by 46,123bps in 2023.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Operating Margin stood at -451.48% in 2021, then soared by 21,323bps to -238.25% in 2022, then spiked by 9,794bps to -140.30% in 2023, then soared by 18,948bps to 49.18% in 2024, then slumped by 12,627bps to -268.63% in 2025.
  • Its Operating Margin was -268.63% in Q3 2025, compared to -324.21% in Q2 2025 and -425.76% in Q1 2025.